Relationship between immunoinflammatory proteins containing sialic acid and low-density lipoprotein serum concentrations

Clinica Chimica Acta

Volumn 252, Issue 1, 1996, Pages 21-31

  Sarria A ^a   Moreno, L A ^a   Mur, M ^a   Lazaro A ^a   Lasierra, M P ^a   Roda, L ^a   Giner, A ^a   Larrad, L ^a   Bueno, M ^a  

^a HOSPITAL CLÍNICO UNIVERSITARIO LOZANO BLESA   (Spain)

Author keywords

Atherosclerosis; Children; Complement components; Glycoproteins; Immunoglobulins; Low density lipoprotein cholesterol

Indexed keywords

ALPHA 1 ANTITRYPSIN; ALPHA 2 MACROGLOBULIN; ALPHA1 GLYCOPROTEIN; CERULOPLASMIN; CHOLESTEROL; COMPLEMENT COMPONENT C3; HAPTOGLOBIN; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; LOW DENSITY LIPOPROTEIN CHOLESTEROL; SIALOGLYCOPROTEIN; TRANSFERRIN;

ADOLESCENT; ARTICLE; ATHEROSCLEROSIS; BLOOD ANALYSIS; CONTROLLED STUDY; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; RISK FACTOR;

EID: 0030586969     PISSN: 00098981     EISSN: None     Source Type: Journal    
DOI: 10.1016/0009-8981(96)06307-3     Document Type: Article

References (35)

1. [1] Lindberg G, Eklund GA, Gullberg B, Rasta L. Serum sialic acid concentration and cardiovascular mortality. Br Med J 1991;302:143-146.
2. [2] Lindberg G, Rastam L, Gullberg B, Eklund GA. Serum sialic acid concentration predicts both coronary heart disease and stroke mortality: multivariate analysis including 54 385 men and women during 20.5 years follow-up. Int J Epidemiol 1992;21:253-257.
3. [3] Lindberg G, Rastam L, Gullberg B, Lundblad A, Nilsson-Ehle P, Hanson BS. Serum concentrations of total sialic acid and sialoglycoproteins in relation to coronary heart disease risk markers. Atherosclerosis 1993;103:123-129.
4. [4] Reunanen A, Knekt P, Ritva-Kaarina A. Serum ceruloplasmin level and the risk of myocardial infarction and stroke. Am J Epidemiol 1992;136:1082-1090.
5. [5] Muscari A, Bozzoli C, Gerratama C et al. Association of serum Ig A and C4 with severe atherosclerosis. Atherosclerosis 1988;74:179-186.
6. [6] Hollander W, Colombo MA, Kirkpatrick B, Paddock J. Soluble proteins in the human atherosclerotic plaque. With special reference to immunoglobulins, C3-complement component, alfa-1-antitrypsin and alfa-2-macroglobulin. Atherosclerosis 1979;34:391-405.
7. [7] Stastny JJ, Fosslien E. Quantitative alteration of some aortic intima proteins in fatty streaks and fibro-fatty lesions. Exp Mol Pathol 1992;57:205-214
8. [8] Muscari A, Bozzoli C, Puddu GM et al. Correlations between serum lipids and complement components in adults without demonstrated atherosclerotic disease. Atherosclerosis 1990;81:111-118.
9. [9] Sarría A, Moreno L, Fleta J et al. Immunoglobulins, complement components and lymphocyte subsets are related to plasma lipoproteins in healthy children. Atherosclerosis 1992;93:157-159.
10. [10] Allain CC, Poon LS, Chan CSG, Richmond W. Enzymatic determination of total serum cholesterol. Clin Chem 1974;20:470-475.
11. [11] Fossati P, Prencipe L. Serum triglycerides determined colorimetrically with an enzyme that produces hydrogen peroxide. Clin Chem 1982;28:2077-2080.
12. [12] Nguyen T, Albers A. Comparison of improved precipitation methods for quantification of high-density lipoprotein cholesterol. Clin Chem 1985;31:217-222.
13. [13] Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of preparative ultracentrifuge. Clin Chem 1972;18:499-502.
14. [14] Sternberg JC. A rate nephelometer for measuring specific proteins by immunoprecipitin reactions. Clin Chem 1977;23:1456-1464.
15. [15] Sarría A, Moreno LA, Mur M, Lázaro A, Bueno M. Usefulness of serum apolipoprotein B levels for screening children with primary dyslipoproteinemias. Am J Dis Child 1992:146:1230-1231.
16. [16] Berenson GS, Wattigney WA, Tracy RE et al. Atherosclerosis of the aorta and coronary arteries and cardiovascular risk factors in persons aged 6 to 30 years and studied at necropsy (The Bogalusa Heart Study). Am J cardiol 1992;70:851-858.
17. [17] Plaza I y Grupo de Expertes de las Sociedades Españolas de Arteriosclerosis, Cardiología, Pediatría, Nutrición y Medicina Preventiva. Informe sobre el colesterol en niños y adolescentes españoles. Clin Invest Arteriosclerosis 1991;3:47-66.
18. [18] Sigal LH. The acute phase response to inflammation. In: Sigal LH, Ron Y, eds. New York: MacGraw-Hill, 1994;287-301.
19. 1-acid glycoprotein fraction from the urine of nephrotic patients. Biochim Biophys Acta 1980;617:514-523.
20. [20] Eisenberg S. High density lipoprotein metabolism. J Lipid Res 1984;25:1017-1071.
21. [21] Johansson J, Egberg N, Johnsson H, Carlson LA. Serum lipoproteins and hemostatic function in intermittent claudication. Arterioscler Thromb 1993;13:1441-1448.
22. [22] Mohacsi A, Fulop T, Kozlovszky B, Hauck M, Kiss I, Leovey A. Sera and leukocyte elastase-type protease and antiprotease activity in healthy and atherosclerotic subjects of various ages. J Gerontol 1992;47:B154-158
23. [23] Stocks J, Gutteridge JMC, Sharp RJ, Dormandy TL. The inhibition of lipid autoxidation by human serum and its relation to serum proteins and α-tocopherol. Clin Sci Mol Med 1974;47:223-233.
24. [24] Magnusson MK, Sigfusson N, Sigvaldason H, Johannesson GM, Magnusson S, Thorgeirsson G. Low iron-binding capacity as a risk factor for myocardial infarction. Circulation 1994;89:102-108.
25. [25] Liao Y, Cooper RS, McGee DL. Iron status and coronary heart disease: negative findings from the NHANES I epidemiologic follow-up study. Am J Epidemiol 1994:139:704-712.
26. [26] Sempos CT, Looker AC, Gillum RF, Makuc DM. Body iron stores and the risk of coronary heart disease. N Engl J Med 1994;330:1119-1124.
27. [27] Hansson GK. Immune and inflammatory mechanisms in the development of atherosclerosis. Br Heart J 1993;69(Suppl.):538-541.
28. [28] Sarría A, Moreno LA, Mur M et al. Lymphocyte T subset counts in children with elevated low-density lipoprotein cholesterol levels. Atherosclerosis 1995;117:119-123.
29. [29] Moreno L, Sarría A, Lázaro A, Bueno M, Larrad L. Serum C4 concentration and risk of atherosclerosis. Br Med J 1994;309:1087.
30. [30] Seifert PS, Hansson GK. Complement receptors and regulatory proteins in human atherosclerotic lesions. Arteriosclerosis 1989;9:802-808
31. [31] Vlaicu R, Niculescu F, Rus HG, Cristea A. Immunohistochemical localization of the terminal C5b-9 complement complex in human aortic fibrous plaque. Atherosclerosis 1985;57:163-167.
32. [32] Vallee BL. The time course of serum copper concentrations of patients with myocardial infarction. I. Metabolism 1952;1:420-434.
33. [33] Manthey J, Stoeppler M, Morgenstern W et al. Magnesium and trace metals: risk factors for coronary heart disease? Associations between blood levels and angio-graphic findings. Circulation 1981;64:722-729.
34. [34] Ehrenwald E, Chisolm GM, Fox PL. Intact human ceruloplasmin oxidatively modifies low density lipoprotein. J Clin Invest 1994;93:1493-1501.
35. [35] Moreno LA, Sarría A, Mur M et al. Serum bilirubin concentrations in children at risk for atherosclerosis. Clin Chem 1994;40:1791-1792.